Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 299

1.

Injecting-related trust, cooperation, intimacy, and power as key factors influencing risk perception among drug injecting partnerships.

Morris MD, Andrew E, Tan JY, Maher L, Hoff C, Darbes L, Page K.

PLoS One. 2019 May 31;14(5):e0217811. doi: 10.1371/journal.pone.0217811. eCollection 2019.

2.

Role of HCV Viremia in Corroborated HCV Transmission Events Within Young Adult Injecting Partnerships.

Hahn JA, Tully DC, Evans JL, Morris MD, Briceno A, Bean DJ, Allen TM, Page K.

Open Forum Infect Dis. 2019 Apr 25;6(4):ofz125. doi: 10.1093/ofid/ofz125. eCollection 2019 Apr.

3.

Effects of a voter initiative on disparities in punishment severity for drug offenses across California counties.

Mooney AC, Neilands TB, Giannella E, Morris MD, Tulsky J, Glymour MM.

Soc Sci Med. 2019 Jun;230:9-19. doi: 10.1016/j.socscimed.2019.03.010. Epub 2019 Mar 11.

PMID:
30947103
4.

Treatment cascade for hepatitis C virus in young adult people who inject drugs in San Francisco: Low number treated.

Morris MD, Mirzazadeh A, Evans JL, Briceno A, Coffin P, Hahn JA, Page KA.

Drug Alcohol Depend. 2019 May 1;198:133-135. doi: 10.1016/j.drugalcdep.2019.02.008. Epub 2019 Feb 27.

PMID:
30921649
5.

Sex discrepancies in the protective effect of opioid agonist therapy on incident hepatitis C infection.

Geddes L, Iversen J, Wand H, Esmaeili A, Tsui J, Hellard M, Dore G, Grebely J, Dietze P, Bruneau J, Prins M, Morris MD, Shoukry NH, Lloyd AR, Kim AY, Lauer G, Cox AL, Page K, Maher L; InC3 Collaborative.

Clin Infect Dis. 2019 Feb 28. pii: ciz162. doi: 10.1093/cid/ciz162. [Epub ahead of print]

PMID:
30816419
6.

External Bone Size Is a Key Determinant of Strength-Decline Trajectories of Aging Male Radii.

Bigelow EM, Patton DM, Ward FS, Ciarelli A, Casden M, Clark A, Goulet RW, Morris MD, Schlecht SH, Mandair GS, Bredbenner TL, Kohn DH, Jepsen KJ.

J Bone Miner Res. 2019 May;34(5):825-837. doi: 10.1002/jbmr.3661. Epub 2019 Feb 4.

PMID:
30715752
7.

Dual Unsafe Injection and Sexual Behaviors for HIV Infection Among People Who Inject Drugs in Iran.

Esmaeili A, Shokoohi M, Danesh A, Sharifi H, Karamouzian M, Haghdoost A, Shahesmaeili A, Akbarpour S, Morris MD, Mirzazadeh A.

AIDS Behav. 2019 Jun;23(6):1594-1603. doi: 10.1007/s10461-018-2345-5.

PMID:
30460664
8.

Examining the influence of PTH(1-34) on tissue strength and composition.

Gardinier JD, Al-Omaishi S, Rostami N, Morris MD, Kohn DH.

Bone. 2018 Dec;117:130-137. doi: 10.1016/j.bone.2018.09.019. Epub 2018 Sep 24.

PMID:
30261327
9.

Correction: Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF; End Hep C SF.

PLoS One. 2018 Jul 12;13(7):e0200866. doi: 10.1371/journal.pone.0200866. eCollection 2018.

10.

Racial/Ethnic Disparities in Arrests for Drug Possession After California Proposition 47, 2011-2016.

Mooney AC, Giannella E, Glymour MM, Neilands TB, Morris MD, Tulsky J, Sudhinaraset M.

Am J Public Health. 2018 Aug;108(8):987-993. doi: 10.2105/AJPH.2018.304445. Epub 2018 Jun 21.

11.

Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination.

Facente SN, Grebe E, Burk K, Morris MD, Murphy EL, Mirzazadeh A, Smith AA, Sanchez MA, Evans JL, Nishimura A, Raymond HF; End Hep C SF.

PLoS One. 2018 Apr 11;13(4):e0195575. doi: 10.1371/journal.pone.0195575. eCollection 2018. Erratum in: PLoS One. 2018 Jul 12;13(7):e0200866.

12.

Illicit Drug Users in the Tanzanian Hinterland: Population Size Estimation Through Key Informant-Driven Hot Spot Mapping.

Ndayongeje J, Msami A, Laurent YI, Mwankemwa S, Makumbuli M, Ngonyani AM, Tiberio J, Welty S, Said C, Morris MD, McFarland W.

AIDS Behav. 2018 Jul;22(Suppl 1):4-9. doi: 10.1007/s10461-018-2057-x.

13.

A Study of Sexual Relationship Power among Young Women Who Inject Drugs and Their Sexual Partners.

Morris MD, Montgomery ME, Briceno A, Evans JL, Andrew EVW, Page K, Hahn JA.

Subst Use Misuse. 2018 Jul 3;53(8):1281-1287. doi: 10.1080/10826084.2017.1404105. Epub 2017 Dec 29.

14.

Bone morphogenetic protein signaling through ACVR1 and BMPR1A negatively regulates bone mass along with alterations in bone composition.

Shi C, Mandair GS, Zhang H, Vanrenterghem GG, Ridella R, Takahashi A, Zhang Y, Kohn DH, Morris MD, Mishina Y, Sun H.

J Struct Biol. 2018 Mar;201(3):237-246. doi: 10.1016/j.jsb.2017.11.010. Epub 2017 Nov 23.

15.

Context and characteristics of illicit drug use in coastal and interior Tanzania.

Tiberio J, Laurent YI, Ndayongeje J, Msami A, Welty S, Ngonyani A, Mwankemwa S, Makumbuli M, McFarland W, Morris MD.

Int J Drug Policy. 2018 Jan;51:20-26. doi: 10.1016/j.drugpo.2017.09.012. Epub 2017 Nov 16.

PMID:
29156310
16.

The Effect of Female Sex on Hepatitis C Incidence Among People Who Inject Drugs: Results From the International Multicohort InC3 Collaborative.

Esmaeili A, Mirzazadeh A, Morris MD, Hajarizadeh B, Sacks HS, Maher L, Grebely J, Kim AY, Lauer G, Cox AL, Hellard M, Dietze P, Bruneau J, Shoukry NH, Dore GJ, Lloyd AR, Prins M, Page K; InC3 Collaborative.

Clin Infect Dis. 2018 Jan 6;66(1):20-28. doi: 10.1093/cid/cix768.

17.

Universal opt-out screening for hepatitis C virus (HCV) within correctional facilities is an effective intervention to improve public health.

Morris MD, Brown B, Allen SA.

Int J Prison Health. 2017 Sep 11;13(3-4):192-199. doi: 10.1108/IJPH-07-2016-0028.

18.

An Improved Version of a Tool Mark Comparison Algorithm.

Hadler JR, Morris MD.

J Forensic Sci. 2018 May;63(3):849-855. doi: 10.1111/1556-4029.13640. Epub 2017 Sep 8.

PMID:
28886221
19.

Development and validation of a novel scale for measuring interpersonal factors underlying injection drug using behaviours among injecting partnerships.

Morris MD, Neilands TB, Andrew E, Maher L, Page KA, Hahn JA.

Int J Drug Policy. 2017 Oct;48:54-62. doi: 10.1016/j.drugpo.2017.05.030. Epub 2017 Aug 9.

20.

Geographic Differences in Temporal Incidence Trends of Hepatitis C Virus Infection Among People Who Inject Drugs: The InC3 Collaboration.

Morris MD, Shiboski S, Bruneau J, Hahn JA, Hellard M, Prins M, Cox AL, Dore G, Grebely J, Kim AY, Lauer GM, Lloyd A, Rice T, Shoukry N, Maher L, Page K; International Collaboration of Incident HIV and HCV in Injecting Cohorts (InC3).

Clin Infect Dis. 2017 Apr 1;64(7):860-869. doi: 10.1093/cid/ciw869. Erratum in: Clin Infect Dis. 2017 Aug 15;65(4):706-707.

21.

Limited naturally occurring escape in broadly neutralizing antibody epitopes in hepatitis C glycoprotein E2 and constrained sequence usage in acute infection.

Rodrigo C, Walker MR, Leung P, Eltahla AA, Grebely J, Dore GJ, Applegate T, Page K, Dwivedi S, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Luciani F, Lloyd AR, Bull RA; InC(3) Study Group.

Infect Genet Evol. 2017 Apr;49:88-96. doi: 10.1016/j.meegid.2017.01.006. Epub 2017 Jan 5.

22.

Combined reflectance and Raman spectroscopy to assess degree of in vivo angiogenesis after tissue injury.

Agarwal S, Lloyd WR, Loder SJ, Chung MT, Hwang C, Morris MD, Levi B.

J Surg Res. 2017 Mar;209:174-177. doi: 10.1016/j.jss.2016.09.017. Epub 2016 Sep 19.

23.

Phylogenetic analysis of full-length, early infection, hepatitis C virus genomes among people with intravenous drug use: the InC3 Study.

Rodrigo C, Eltahla AA, Bull RA, Luciani F, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Shoukry NH, Lauer GM, Maher L, Schinkel J, Prins M, Hellard M, Lloyd AR; InC3 Collaborative.

J Viral Hepat. 2017 Jan;24(1):43-52. doi: 10.1111/jvh.12616. Epub 2016 Nov 3.

24.

Raman microscopy of bladder cancer cells expressing green fluorescent protein.

Mandair GS, Han AL, Keller ET, Morris MD.

J Biomed Opt. 2016 Nov 1;21(11):115001. doi: 10.1117/1.JBO.21.11.115001.

PMID:
27805248
25.

Design and microfabrication of a miniature fiber optic probe with integrated lenses and mirrors for Raman and fluorescence measurements.

Ngernsutivorakul T, Cipolla CM, Dugan CE, Jin S, Morris MD, Kennedy RT, Esmonde-White FW.

Anal Bioanal Chem. 2017 Jan;409(1):275-285. doi: 10.1007/s00216-016-9999-5. Epub 2016 Oct 20.

26.

Analysis of resistance-associated substitutions in acute hepatitis C virus infection by deep sequencing across six genotypes and three continents.

Eltahla AA, Rodrigo C, Betz-Stablein B, Grebely J, Applegate T, Luciani F, Schinkel J, Dore GJ, Page K, Bruneau J, Morris MD, Cox AL, Kim AY, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Lloyd AR, Bull RA; InC3 Study Group.

J Viral Hepat. 2017 Jan;24(1):37-42. doi: 10.1111/jvh.12615. Epub 2016 Sep 25.

27.

Historical Trends in the Hepatitis C Virus Epidemics in North America and Australia.

Rodrigo C, Eltahla AA, Bull RA, Grebely J, Dore GJ, Applegate T, Page K, Bruneau J, Morris MD, Cox AL, Osburn W, Kim AY, Schinkel J, Shoukry NH, Lauer GM, Maher L, Hellard M, Prins M, Estes C, Razavi H, Lloyd AR, Luciani F; International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3) Study Group.

J Infect Dis. 2016 Nov 1;214(9):1383-1389. Epub 2016 Aug 28.

28.

Selective detection and complete identification of triglycerides in cortical bone by high-resolution (1)H MAS NMR spectroscopy.

Mroue KH, Xu J, Zhu P, Morris MD, Ramamoorthy A.

Phys Chem Chem Phys. 2016 Jul 28;18(28):18687-91. doi: 10.1039/c6cp03506j. Epub 2016 Jul 4.

29.

Loss of BMP signaling through BMPR1A in osteoblasts leads to greater collagen cross-link maturation and material-level mechanical properties in mouse femoral trabecular compartments.

Zhang Y, McNerny EG, Terajima M, Raghavan M, Romanowicz G, Zhang Z, Zhang H, Kamiya N, Tantillo M, Zhu P, Scott GJ, Ray MK, Lynch M, Ma PX, Morris MD, Yamauchi M, Kohn DH, Mishina Y.

Bone. 2016 Jul;88:74-84. doi: 10.1016/j.bone.2016.04.022. Epub 2016 Apr 23.

30.

Interferon Lambda 4 Genotype Is Associated With Jaundice and Elevated Aminotransferase Levels During Acute Hepatitis C Virus Infection: Findings From the InC3 Collaborative.

Page K, Mirzazadeh A, Rice TM, Grebely J, Kim AY, Cox AL, Morris MD, Hellard M, Bruneau J, Shoukry NH, Dore GJ, Maher L, Lloyd AR, Lauer G, Prins M, McGovern BH.

Open Forum Infect Dis. 2016 Feb 8;3(1):ofw024. doi: 10.1093/ofid/ofw024. eCollection 2016 Jan.

31.

Parathyroid hormone attenuates radiation-induced increases in collagen crosslink ratio at periosteal surfaces of mouse tibia.

Oest ME, Gong B, Esmonde-White K, Mann KA, Zimmerman ND, Damron TA, Morris MD.

Bone. 2016 May;86:91-97. doi: 10.1016/j.bone.2016.03.003. Epub 2016 Mar 4.

32.

PTH signaling mediates perilacunar remodeling during exercise.

Gardinier JD, Al-Omaishi S, Morris MD, Kohn DH.

Matrix Biol. 2016 May-Jul;52-54:162-175. doi: 10.1016/j.matbio.2016.02.010. Epub 2016 Feb 23.

33.

Effect of anti-sclerostin therapy and osteogenesis imperfecta on tissue-level properties in growing and adult mice while controlling for tissue age.

Sinder BP, Lloyd WR, Salemi JD, Marini JC, Caird MS, Morris MD, Kozloff KM.

Bone. 2016 Mar;84:222-229. doi: 10.1016/j.bone.2016.01.001. Epub 2016 Jan 6.

34.

More than just someone to inject drugs with: Injecting within primary injection partnerships.

Morris MD, Bates A, Andrew E, Hahn J, Page K, Maher L.

Drug Alcohol Depend. 2015 Nov 1;156:275-281. doi: 10.1016/j.drugalcdep.2015.09.025. Epub 2015 Sep 30.

35.

Raman spectroscopy for label-free identification of calciphylaxis.

Lloyd WR, Agarwal S, Nigwekar SU, Esmonde-White K, Loder S, Fagan S, Goverman J, Olsen BR, Jumlongras D, Morris MD, Levi B.

J Biomed Opt. 2015 Aug;20(8):80501. doi: 10.1117/1.JBO.20.8.080501.

36.

Proton-Detected Solid-State NMR Spectroscopy of Bone with Ultrafast Magic Angle Spinning.

Mroue KH, Nishiyama Y, Kumar Pandey M, Gong B, McNerny E, Kohn DH, Morris MD, Ramamoorthy A.

Sci Rep. 2015 Jul 8;5:11991. doi: 10.1038/srep11991.

37.

Response to treatment following recently acquired hepatitis C virus infection in a multicentre collaborative cohort.

Doyle JS, Deterding K, Grebely J, Wedemeyer H, Sacks-Davis R, Spelman T, Matthews G, Rice TM, Morris MD, McGovern BH, Kim AY, Bruneau J, Lloyd AR, Page K, Manns MP, Hellard ME, Dore GJ; InC3 Study Group.

J Viral Hepat. 2015 Dec;22(12):1020-32. doi: 10.1111/jvh.12429. Epub 2015 Jun 22.

38.

A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugs.

Spelman T, Morris MD, Zang G, Rice T, Page K, Maher L, Lloyd A, Grebely J, Dore GJ, Kim AY, Shoukry NH, Hellard M, Bruneau J; International Collaborative of Incident HIV and Hepatitis C in Injecting Cohorts (InC3 Study).

J Epidemiol Community Health. 2015 Aug;69(8):745-52. doi: 10.1136/jech-2014-205224. Epub 2015 Mar 26.

39.

Next-generation Raman tomography instrument for non-invasive in vivo bone imaging.

Demers JL, Esmonde-White FW, Esmonde-White KA, Morris MD, Pogue BW.

Biomed Opt Express. 2015 Feb 11;6(3):793-806. doi: 10.1364/BOE.6.000793. eCollection 2015 Mar 1.

40.

Tissue phantoms to compare spatial and temporal offset modes of deep Raman spectroscopy.

Iping Petterson IE, Esmonde-White FW, de Wilde W, Morris MD, Ariese F.

Analyst. 2015 Apr 7;140(7):2504-12. doi: 10.1039/c4an01889c.

PMID:
25665820
41.

Contributions of Raman spectroscopy to the understanding of bone strength.

Mandair GS, Morris MD.

Bonekey Rep. 2015 Jan 7;4:620. doi: 10.1038/bonekey.2014.115. eCollection 2015. Review.

42.

Vibrational spectroscopy and imaging.

Mahadevan-Jansen A, Morris MD, Petrich W.

J Biomed Opt. 2014;19(11):111601. doi: 10.1117/1.JBO.19.11.111601. No abstract available.

PMID:
25389567
43.

Raman spectroscopy delineates radiation-induced injury and partial rescue by amifostine in bone: a murine mandibular model.

Felice PA, Gong B, Ahsan S, Deshpande SS, Nelson NS, Donneys A, Tchanque-Fossuo C, Morris MD, Buchman SR.

J Bone Miner Metab. 2015 May;33(3):279-84. doi: 10.1007/s00774-014-0599-1. Epub 2014 Oct 16.

44.

Intimate injection partnerships are at elevated risk of high-risk injecting: a multi-level longitudinal study of HCV-serodiscordant injection partnerships in San Francisco, CA.

Morris MD, Evans J, Montgomery M, Yu M, Briceno A, Page K, Hahn JA.

PLoS One. 2014 Oct 6;9(10):e109282. doi: 10.1371/journal.pone.0109282. eCollection 2014.

45.

Treatment of heterotopic ossification through remote ATP hydrolysis.

Peterson JR, De La Rosa S, Eboda O, Cilwa KE, Agarwal S, Buchman SR, Cederna PS, Xi C, Morris MD, Herndon DN, Xiao W, Tompkins RG, Krebsbach PH, Wang SC, Levi B.

Sci Transl Med. 2014 Sep 24;6(255):255ra132. doi: 10.1126/scitranslmed.3008810.

46.

Bone fracture toughness and strength correlate with collagen cross-link maturity in a dose-controlled lathyrism mouse model.

McNerny EM, Gong B, Morris MD, Kohn DH.

J Bone Miner Res. 2015 Mar;30(3):455-64. doi: 10.1002/jbmr.2356.

47.

Effects of aging on osteogenic response and heterotopic ossification following burn injury in mice.

Peterson JR, Eboda ON, Brownley RC, Cilwa KE, Pratt LE, De La Rosa S, Agarwal S, Buchman SR, Cederna PS, Morris MD, Wang SC, Levi B.

Stem Cells Dev. 2015 Jan 15;24(2):205-13. doi: 10.1089/scd.2014.0291.

48.

Early detection of heterotopic ossification using near-infrared optical imaging reveals dynamic turnover and progression of mineralization following Achilles tenotomy and burn injury.

Perosky JE, Peterson JR, Eboda ON, Morris MD, Wang SC, Levi B, Kozloff KM.

J Orthop Res. 2014 Nov;32(11):1416-23. doi: 10.1002/jor.22697. Epub 2014 Aug 2.

49.

Concordance of risk behavior reporting within HCV serodiscordant injecting partnerships of young injection drug users in San Francisco, CA.

Evans JL, Morris MD, Yu M, Page K, Hahn JA.

Drug Alcohol Depend. 2014 Sep 1;142:239-44. doi: 10.1016/j.drugalcdep.2014.06.028. Epub 2014 Jul 4.

50.

Acceleration of natural-abundance solid-state MAS NMR measurements on bone by paramagnetic relaxation from gadolinium-DTPA.

Mroue KH, Zhang R, Zhu P, McNerny E, Kohn DH, Morris MD, Ramamoorthy A.

J Magn Reson. 2014 Jul;244:90-7. doi: 10.1016/j.jmr.2014.04.020. Epub 2014 May 10.

Supplemental Content

Loading ...
Support Center